Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.37 |
| ▸ | CRHBP | P24387 | 1/20 | 0.37 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.37 |
| ▸ | KLK7 | P49862 | 1/20 | 0.37 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.37 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11653074 | 1.00 | ADORA2A (0.41) | ADORA2AADORA2BADORA1POLBAPP | |
| SCHEMBL7618854 | 0.83 | — | — | |
| SCHEMBL7474650 | 0.83 | — | — | |
| SCHEMBL18655709 | 0.83 | — | — | |
| SCHEMBL667301 | 0.79 | ALDH1A1 (0.46) | KDM4EALDH1A1KMT2AMAPTLMNA | |
| SCHEMBL2671868 | 0.79 | CYP2C9 (0.43) | ADORA2AADORA2BADORA1POLBAPP | |
| SCHEMBL2671866 | 0.79 | CYP2C9 (0.43) | ADORA2AADORA2BADORA1POLBAPP | |
| SCHEMBL11653026 | 0.79 | ALDH1A1 (0.46) | KDM4EALDH1A1KMT2AMAPTLMNA | |
| SCHEMBL31636860 | 0.79 | CYP2C9 (0.61) | POLBKDM4EALDH1A1KMT2AMAPT | |
| SCHEMBL28549047 | 0.79 | CYP1A2 (0.34) | KDM4EALDH1A1CYP2C9NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10471174-B2 | Cyanoacrylate medical adhesive and preparation method and use thereof | Shen, Wei (CN) | 2019-11-12 | — | — | US | claimed |
| EP-3335738-B1 | NEW TYPE CYANOACRYLATE MEDICAL ADHESIVE AND PREPARATION METHOD AND USE THEREOF | SHEN WEI (CN) | 2019-11-06 | — | — | EP | claimed |
| US-20190175782-A1 | NOVEL CYANOACRYLATE MEDICAL ADHESIVE AND PREPARATION METHOD AND USE THEREOF | SHEN, WEI (CN) | 2019-06-13 | — | — | US | claimed |
| EP-3335738-A1 | NEW TYPE CYANOACRYLATE MEDICAL ADHESIVE AND PREPARATION METHOD AND USE THEREOF | Shen, Wei (CN) | 2018-06-20 | — | — | EP | claimed |
| US-4933220-A | Using cyanoacrylate | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1990-06-12 | — | — | US | claimed |
| CN-115215767-B | Process for preparing 2-cyano-3-ethoxyacrylic acid ethyl ester derivative | 帕潘纳(北京)科技有限公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-115215767-A | Process for preparing 2-cyano-3-ethoxy ethyl acrylate derivatives | 帕潘纳(北京)科技有限公司 | 2022-10-21 | — | — | CN | disclosed |
| US-10471174-B2 | Cyanoacrylate medical adhesive and preparation method and use thereof | Shen, Wei (CN) | 2019-11-12 | — | — | US | disclosed |
| EP-3335738-B1 | NEW TYPE CYANOACRYLATE MEDICAL ADHESIVE AND PREPARATION METHOD AND USE THEREOF | SHEN WEI (CN) | 2019-11-06 | — | — | EP | disclosed |
| US-20190175782-A1 | NOVEL CYANOACRYLATE MEDICAL ADHESIVE AND PREPARATION METHOD AND USE THEREOF | SHEN, WEI (CN) | 2019-06-13 | — | — | US | disclosed |
| EP-3335738-A1 | NEW TYPE CYANOACRYLATE MEDICAL ADHESIVE AND PREPARATION METHOD AND USE THEREOF | Shen, Wei (CN) | 2018-06-20 | — | — | EP | disclosed |
| US-20160264587-A1 | Compounds Useful for Inhibiting Metastasis from Cancer and Methods Using Same | UNIV DREXEL (US) | 2016-09-15 | — | — | US | disclosed |
| US-6977278-B1 | Cyanoacrylate compositions curable to flexible polymeric materials | LOCTITE (R&D) LTD. (IE) | 2005-12-20 | — | — | US | disclosed |
| EP-1360257-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | Loctite (R & D) Limited (IE) | 2003-11-12 | — | — | EP | disclosed |
| WO-2002053666-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE (R & D) LIMITED (IE) | 2002-07-11 | — | — | WO | disclosed |
| US-4987232-A | ONE POT, GOOD YIELD | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ, B.V. (NL) | 1991-01-22 | — | — | US | disclosed |
| EP-0372654-A2 | Preparation of 2-chloropyridine 3-carboxylic acid esters | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1990-06-13 | — | — | EP | disclosed |
| US-4665218-A | Method for the preparation of alkoxymethylene compounds of acetic esters and substituted acetic esters | DYNAMIT NOBEL AG (DE) | 1987-05-12 | — | — | US | disclosed |
| US-4559342-A | Quinolone acids and antibacterial agents containing these compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1985-12-17 | — | — | US | disclosed |
| US-4104049-A | Chlorine-substituted vinylaminobenzoic acid compounds and plant growth regulant compositions | BAYER AKTIENGESELLSCHAFT (DE) | 1978-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160264587-A1 | Compounds Useful for Inhibiting Metastasis from Cancer and Methods Using Same | CX3CR1, CCL2, CCR5 | ADORA2A 302/4885ADORA2B 839/4885ADORA1 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.